Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Karl Hård, Head of Investor Relations & Communications
karl.hard@egetis.com Phone: +46 733 011 944
Nicklas Westerholm, CEO
nicklas.westerholm@egetis.com
Yilmaz Mahshid, CFO
yilmaz.mahshid@egetis.com
December 14, 2023
DNB Nordic Healthcare Conference
December 19, 2023
Egetis Investor Day
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
